Drugs / AZD9898
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03140072 | May → Aug 2017 | asthma | AstraZeneca | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD9898 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03140072 ↗ |
| Modality | Small molecule | — CHEMBL3961833 ↗ |
| Route | Oral | “Single and Multiple Ascending Oral Doses of AZD9898 in Healthy Volunteers and Asthma Patients.” NCT03140072 ↗ |